Thyroid receptor agonists for the treatment of androgenetic alopecia

Bioorg Med Chem Lett. 2010 Jan 1;20(1):306-8. doi: 10.1016/j.bmcl.2009.10.109. Epub 2009 Oct 29.

Abstract

A thyroid hormone receptor beta subtype-selective thyromimetic 5 was found to be efficacious in both mouse and monkey hair growth models after topical applications. It penetrates the skin according to the test in human cadaver skin mounted onto Franz diffusion chambers. The serum drug level of 5 is below the limit of quantification during tests in the bald stump-tailed macaques (Macaca arctoides). It is tested negative in the 3T3 neutral red uptake (NRU) phototoxicity test, indicating a low risk for causing photo-irritation. It is also rapidly metabolized according to the PK data, thus the systemic exposure is limited.

MeSH terms

  • Administration, Topical
  • Alopecia / drug therapy*
  • Animals
  • BALB 3T3 Cells
  • Hair / growth & development
  • Humans
  • Macaca
  • Mice
  • Neutral Red / metabolism
  • Receptors, Thyroid Hormone / agonists*
  • Receptors, Thyroid Hormone / metabolism
  • Skin Absorption
  • Triazines / chemical synthesis
  • Triazines / chemistry*
  • Triazines / toxicity

Substances

  • PF 00277343
  • Receptors, Thyroid Hormone
  • Triazines
  • Neutral Red